One more view of neurotrophin-netrotrasmitter signaling in neurons: BDNF-AMPAR crosstalk

Biomedical Reviews

Volumn 19, Issue , 2008, Pages 29-32

  Chaldakov, George N ^a  

^a MEDICAL UNIVERSITY OF VARNA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80051532181     PISSN: 1310392X     EISSN: None     Source Type: Journal    
DOI: 10.14748/bmr.v19.58     Document Type: Editorial

References (43)

1. Georgiev DD, Taniura H, Kambe Y, Yoneda Y. Crosstalk between brain-derived neurotrophic factor and N-methyl- D-aspartate receptor signaling in neurons. Biomed Rev 2008; 19: 17-27.
2. Levi-Montalcini R. The nerve growth factors 35 years later. Science 1987; 237: 1154-1162.
3. Aloe L, Calzá L, editors. NGF and Related Molecules in Health and Disease. Prog Brain Res 2004; 146: 1-544.
4. Chaldakov GN, Fiore M, Tonchev AB, Dimitrov D, Pancheva R, Rančič G, et al. Homo obesus: a metabotrophin- deficient species. Pharmacology and nutrition insight. Curr Pharm Des 2007; 13: 2176-2179.
5. Snider WD, Lichtman JW. Are neurotrophins synaptotrophins? Mol Cell Neurosci 1996; 7: 433-442.
6. Lu B. Acute and long-term synaptic modulation by neurotrophins. Prog Brain Res 2004; 146: 137-150.
7. Rex CS, Lin CY, Kramar EA, Chen LY, Gall CM, Lynch G. Brain-derived neurotrophic factor promotes long-term potentiation-related cytoskeletal changes in adult hippocampus. J Neurosci 2007: 27: 3017-3029.
8. Gómez-Palacio SA, Escobar-Rodríguez ML. Codificación y retención de la memoria: el factor neurotrófico derivado del cerebro (BDNF) en la plasticidad sináptica. [Memory coding and retention: brain-derived neurotrophic factor (BDNF) in synaptic plasticity] Rev Neurol 2007; 45: 409-417.
9. Tongiorgi E. Activity-dependent expression of braindervied neurotrophic factor in dendrites: Facts and open questions. Neurosci Res 2008; 61: 335-346.
10. Lessmann V. Neurotrophin-dependent modulation of glutamatergic synaptic transmission in the mammalian CNS. Gen Pharmacol 1998; 31: 667-674.
11. Carvalho AL, Caldeira MV, Santos SD, Duarte CB. Role of the brain-derived neurotrophic factor at glutamatergic synapses. Br J Pharmacol 2008; 153: S310-324.
12. Soulé J, Messaoudi E, Bramham CR. Brain-derived neurotrophic factor and control of synaptic consolidation in the adult brain. Biochem Soc Transect 2006; 34: 600-604.
13. Narisawa-Saito M, Wakabayashi K, Tsuji S, Takahashi H, Nawa H. Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease. Neuroreport 1996; 7: 2925-2928.
14. Lu B, Martinowich K. Cell biology of BDNF and its relevance to schizophrenia. Novartis Found Symp 2008; 289: 119-129.
15. Rantamäki T, Castrén E. Targeting TrkB neurotrophin receptor to treat depression. Expert Opin Ther Targets 2008; 13: 705-715.
16. Hardingham GE, Fukunaga Y, Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci 2002; 5: 405-414.
17. Martel MA, Wyllie DJ, Hardingham GE. In developing hippocampal neurons, NR2B-containing N-methyl-Daspartate receptors (NMDARs) can mediate signaling to neuronal survival and synaptic potentiation, as well as neuronal death. Neuroscience 2009; 158: 334-343.
18. Head BP, Patel HH, Tsutsumi YM, Hu Y, Mejia T, Mora RC, et al. Caveolin-1 expression is essential for N-methyl- D-aspartate receptor-mediated Src and extracellular signal-regulated kinase 1/2 activation and protection of primary neurons from ischemic cell death. FASEB J 2008; 22: 828-840.
19. Mizuno M, Yamada K, He J, Nakajima A, Nabeshima T. Involvement of BDNF receptor TrkB in spatial memory formation. Learn Mem 2003; 10: 108-115.
20. Pellegrini-Giampietro DE, Gorter JA, Bennett MV, Zukin RS. The GluR2 (GluR-B) hypothesis: Ca2+-permeable AMPA receptors in neurological disorders. Trends Neurosci 1997; 20: 464-470.
21. Tanaka H, Grooms SY, Bennett MV, Zukin RS. The AMPAR subunit GluR2: still front and center-stage. Brain Res 2000; 886: 190-207.
22. Wang JQ, Arora A, Yang L, Parelkar NK, Zhang G, Liu X, et al. Phosphorylation of AMPA receptors: mechanisms and synaptic plasticity. Mol Neurobiol 2005; 32: 237-249.
23. Payne HL. The role of transmembrane AMPA receptor regulatory proteins (TARPs) in neurotransmission and receptor trafficking. Mol Membr Biol 2008; 25: 353-362.
24. Whitney NP, Peng H, Erdmann NB, Tian C, Monaghan DT, Zheng JC. Calcium-permeable AMPA receptors containing Q/R-unedited GluR2 direct human neural progenitor cell differentiation to neurons. FASEB J 2008; 22: 2888-2900.
25. Lynch G. Glutamate-based therapeutic approaches: ampakines. Curr Opin Pharmacol 2006; 6: 82-88.
26. Lynch G, Gall CM. Ampakines and the threefold path to congnitive enhacement. Trends Neurosci 2006; 29: 554-562.
27. Lynch G, Rex CS, Chen LY, Gall CM. The substrate of memory: Defects, treatments, and enhancement. Eur J Pharmacol 2008; 585: 2-13.
28. Alt A, Witkin JM, Bleakman D. AMPA receptor potentiators as novel antidepressants. Curr Pharm Des 2005; 11: 1511-1527.
29. Li W, Keifer J. Coordinate action of pre- and postsynaptic brain-derived neurotrophic factor is required for AMPAR trafficking and acquisition of in vitro classical conditioning. Neuroscience 2008; 155: 686-697.
30. Ogier M, Wang H, Hong E, Wang Q, Greenberg ME, Katz DM. Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome. J Neurosci 2007; 27: 10912-10917.
31. Arai AC, Kessler M. Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior. Curr Drug Targets 2007; 8: 583-602.
32. Wu X, Zhu D, Jiang X, Okagaki P, Mearow K, Zhu G, et al. AMPA protects cultured neurons against glutamate excitotoxicity through a phosphatidylinositol 3-kinasedependent activation in extracellular signal-regulated kinase to upregulate BDNF gene expression. J Neurochem 2004; 90: 807-818.
33. Kuczewski N, Langlois A, Fiorentino H, Bonnet S, Marissal T, Diabira D, et al. Spontaneous glutamatergic activity induces a BDNF-dependent potentiation of GABAergic synapses in the newborn rat hippocampus. J Physiol 2008; 586: 5119-5128.
34. Madara JC, Levine ES. Presynaptic and postsynaptic NMDA receptors mediate distinct effects of brain-derived neurotrophic factor on synaptic transmission. J Neurophysiol 2008; 100: 3175-3184.
35. Nagano T, Yanagawa Y, Obata K, Narisawa-Saito M, Namba H, Otsu Y, et al. Brain-derived neurotrophic factor upregulates and maintains AMPA receptor currents in neocortical GABAergic neurons. Mol Cell Neurosci 2003; 24: 340-356.
36. Caldeira MV, Melo CV, Pereira DB, Carvalho R, Correia SS, Backos DS, et al. Brain-derived neurotrophic factor regulates the expression and synaptic delivery of alphaamino- 3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunits in hippocampal neurons. J Biol Chem 2007; 282: 12619-12628.
37. Nakata H, Nakamura S. Brain-derived neurotrophic factor regulates AMPA receptor trafficking to post-synaptic densities via IP3R and TRPC calcium signaling. FEBS Letts 2007; 581: 2047-2054.
38. Wu K, Len GW, McAuliffe G, Ma C, Tai JP, Xu F, et al. Brain-derived neurotrophic factor acutely enhances tyrosine phosphorylation of the AMPA receptor subunit GluR1 via NMDA receptor-dependent mechanisms. Brain Res Mol Brain Res 2004;130:178-186.
39. Saxe JG. The Blind Men and the Elephant. In: The Poems of John Godfrey Saxe, Complete Edition. Boston, James R. Osgood and Company, 1873; pp 135-136.
40. Rajagopal R, Chen ZY, Lee FS, Chao MV. Transactivation of Trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes. J Neurosci 2004; 24: 6650-6658.
41. Rajagopal R, Chao MV. A role for Fyn in Trk receptor transactivation by G-protein-coupled receptor signaling. Mol Cell Neurosci 2006; 33: 36-46.
42. Jeanneteau P, Chao MV. Promoting neurotrophic effects by GPCR ligands. Novartis Found Symp 2006; 276: 181-189.
43. Martinowich K, Lu B. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 2008; 33: 73-83.